Home › Pulmonary Hypertension › Oregon › Bend
Pulmonary Hypertension clinical trials in Bend, OR
6 studies for Pulmonary Hypertension are looking for participants at sites in and around Bend (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA003, Bend
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA003, Bend
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- Summit Health, Bend
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Bend Memorial Clinic, Bend
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
RecruitingPhase 3
- Clinical Research Site, Bend
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Summit Health, Bend
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA11 studies
- Aurora, CO9 studies
- Boston, MA8 studies
- Kansas City, KS8 studies
- Cincinnati, OH8 studies
- New York City, NY8 studies
- Rochester, MN7 studies
- Salt Lake City, UT7 studies
- Washington, DC7 studies
- Charleston, SC7 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
Other studies in Bend
- Interstitial Lung Diseases6 studies
- Prostate Cancer5 studies
- Colorectal Cancer5 studies
- Breast Cancer4 studies
- Cancer (all types)3 studies
- Idiopathic Pulmonary Fibrosis3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.